Point72 Asset Management »

Eupraxia Pharmaceuticals shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Eupraxia Pharmaceuticals (EPRX) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Eupraxia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eupraxia Pharmaceuticals held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eupraxia Pharmaceuticals by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.4M 712k 7.55

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amazon (AMZN)
Broadcom (AVGO)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Asml Holding N V N Y Registry Shs (ASML)
Spotify Technology S A SHS (SPOT)
Sea Sponsord Ads (SE)
Biogen Idec (BIIB)
Equinix (EQIX)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Eupraxia Pharmaceuticals

Beutel, Goodman & Company
Vivo Capital
Balyasny Asset Management
Scotia Capital
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
Ikarian Capital
Royal Bank of Canada
Ally Bridge Group
Velan Capital Investment Management
Affinity Asset Advisors
Arrowstreet Capital, Limited Partnership
UBS Group
SummitTX Capital
Marshall Wace

View all funds holding Eupraxia Pharmaceuticals